Abbott Laboratories ABT
NYSE ABT
$115.21 +0.78 (+0.68%)
At close: Aug 20, 2026 · 11:17 AM UTC

Abbott Laboratories (ABT) Cash & Equivalents (QoQ) (2009 - 2026)

Abbott Laboratories (ABT) Cash & Equivalents (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.97%
Mar 31, 2026 -20.17%
Dec 31, 2025 13.46%
Sep 30, 2025 8.06%
Jun 30, 2025 6.41%
Mar 31, 2025 -14.23%
Dec 31, 2024 0.77%
Sep 30, 2024 8.17%
Jun 30, 2024 11.19%
Mar 31, 2024 -8.87%
Dec 31, 2023 2.79%
Sep 30, 2023 -14.37%
Jun 30, 2023 -14.47%
Mar 31, 2023 -7.30%
Dec 31, 2022 3.00%
Sep 30, 2022 7.35%
Jun 30, 2022 16.44%
Mar 31, 2022 -21.68%
Dec 31, 2021 5.34%
Sep 30, 2021 7.44%